Unleash the power of our people

Ensuring Patient Safety in the Era of Automation

Pfizer’s pharmacovigilance organization ensures the safe and appropriate use of the products in our portfolio through the collection, analysis and reporting of safety events. As our portfolio grows and technology evolves, the volume of case reports is increasing. To meet this demand, Pfizer launched an initiative focused on the utilization of artificial intelligence techniques to automate safety case processing activities while maintaining the highest levels of quality and compliance. As we meet the needs of a growing portfolio and an increasing number of patients, we are unleashing the power of our people and shaping the future of pharmacovigilance by working to streamline and optimize adverse event and safety assessment activities.
Unleash the power of our people
Deliver first-in-class science
Transform our go-to-market model
Win the digital race in pharma
Lead the conversation